Featured
Stories
All Stories
Understanding Ovarian Cancer Recurrence: What Every Woman Needs to Know
Article:
HONORING HENRIETTA VILLAESCUSA, RN, FAAN
Article:
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
Press Release: June 5, 2025
Corcept Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet: Relacorilant Improves Progression-Free and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
Press Release: June 2, 2025
HONORING DR. SARA JOSEPHINE BAKER
Article:
HONORING DR. MIN CHIU LI
Article:
Corcept to Present Late-Breaking Data From Pivotal Phase 3 ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ASCO 2025
Press Release: April 23, 2025
Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes
Press Release: April 21, 2025
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
Press Release: Mar 31, 2025